Are you a Veteran of the United States Armed Forces?

Please complete a short survey about prostate cancer care for Veterans to help us learn what's working well and what needs improvement in the care Veterans receive.

Veterans prostate cancer care survey Complete the Survey
Banner_Prostate Cancer News

U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening

Blue sterile gloves holding a petri dish

A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in metastatic prostate cancer diagnoses in the United States, according to results of a study presented at the 2021 ASCO Genitourinary Cancers Symposium.

Between 2008 and 2016, across all states, the mean percentage of men undergoing PSA screening decreased from 61.8% to 50.5%, while the mean incidence of metastatic prostate cancer at diagnosis increased from 6.4 to 9.0 per 100,000 (adjusted P<0.001 for both) (abstract 228).

Read the full article here. 


source: Clinical Oncology

Read More About Prostate Cancer

Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.

Share